The WIRB-Copernicus Group® (WCG) has partnered with Mytrus, Inc.®, a pioneer in technologies that improve clinical trial efficiency, to deliver WCG eConsent™, a unique electronic informed consent solution that streamlines and enriches the clinical research process.
eConsent-logo.pngeConsent-ipad WCG eConsent unites WCG’s deep subject matter expertise with Mytrus’ revolutionary, internet-based platform, bringing unmatched insight and integrity to the consent process. WCG eConsent is powered by Mytrus, and offered as part of a comprehensive ethical oversight solution. Together, WCG and Mytrus ensure that subjects are properly informed, and that sponsors can attain meaningful data regarding patient consent and trial enrollment.

Accessible via iPad®, the eConsent application digitizes and deepens the traditionally paper-based process of obtaining patient consent for participation in clinical trials, increasing efficiency and reducing study start-up time for contract research organizations (CROs) and trial sponsors. The solution uses video, voice instruction and quizzes to maximize patient interaction, which leads to improved comprehension and retention, enabling subjects to make more informed decisions regarding their participation and care.

Translated into many languages, WCG eConsent has been proven most successful in the management of clinical trials involving a diverse subject population. In addition to providing a rich user experience for patients, it generates advanced metrics and aggregate data to optimize the practice of clinical trial management for sponsors and CROs.

Print Friendly